Furthermore, using serum AFP and circulating miRNA-155 together to detect HCC cases provided an advantage over using them separately because the accuracy of combined use of both serum AFP and circulating miRNA-155 was 83.2% while sensitivity and specificity were 83.2% and 95.8%, respectively. Here, AFP is linked to hepatocellular carcinoma.